EBF3 and Alzheimer disease: Knockdown of lncRNA EBF3-AS by siRNA inhibits Aβ25–35 induced apoptosis, thus suggesting that lncRNA EBF3-AS promotes AD neuronal apoptosis and indicating its potential as a new therapeutic target for AD treatment (Gu et al., 2018).